TY - JOUR
KW - Adult
KW - Anxiety/complications/psychology
KW - Case-Control Studies
KW - Cognition
KW - craving
KW - Depression/complications/psychology
KW - Emotions
KW - Female
KW - Heroin/adverse effects
KW - Humans
KW - Male
KW - Psychiatric Status Rating Scales/standards
KW - Psychometrics
KW - Reproducibility of Results
KW - Substance-Related Disorders/complications/psychology
KW - Turkey
KW - Young Adult
KW - Beliefs about substance use
KW - Craving beliefs questionnaire
KW - Heroin
KW - opioid use disorder
AU - M. Kucukkarapinar
AU - H . Y. Eser
AU - V. O. Kotan
AU - M. Yalcinay-Inan
AU - R. Tarhan
AU - Z. Arikan
A1 - 
AB - BACKGROUND: Cognitions associated with craving and substance use are important contributors for the psychological theories of Substance use disorders (SUD), as they may affect the course and treatment. In this study, we aimed to validate Turkish version of two major scales 'Beliefs About Substance Use'(BSU) and 'Craving Beliefs Questionnaire'(CBQ) in patients with heroin use disorder and define the interaction of these beliefs with patient profile, depression and anxiety symptoms, with an aim to use these thoughts as targets for treatment. METHODS: One hundred seventy-six inpatients diagnosed with heroin use disorder and 120 participants in the healthy comparison group were evaluated with CBQ, BSU, Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI) and sociodemographic data questionnaire. Patient group was also evaluated with Addiction Profile Index. Reliability and validity analysis for scales were conducted. Linear regression analysis was conducted to evaluate the determinants of BSU and CBQ scores. RESULTS: Cronbach alpha level was 0.93 for BSU and 0.94 for CBQ. Patient group showed significantly higher CBQ, BSU, BAI and BDI scores (p < 0.001). BSU score significantly correlated with API-substance use profile score, API-diagnosis, BAI, BDI and CBQ (p < 0.005), whereas CBQ scores significantly correlated with API-diagnosis, API-impact on life, API-craving, API-total score, BSU, BAI, BDI and amount of cigarette smoking (p < 0.002). Number of previous treatments and age of onset for substance use were not correlated with either BSU or CBQ. BAI and BDI scores significantly predicted BSU score, however only BDI score predicted CBQ score (p < 0.003). CONCLUSIONS: Craving beliefs were highly correlated with addiction profile. Anxiety and depression are significant modulators for patients' beliefs about substance use and depression is a modulator for craving and maladaptive beliefs, validating emotion-cognition interplay in addiction.
AD - Department of Psychiatry, Mus State Hospital, Mus, Turkey. mdmelikek@gmail.com.; Department of Psychiatry, Gazi University, Faculty of Medicine, Ankara, Turkey. mdmelikek@gmail.com.; Koc University School of Medicine, Istanbul, Turkey & Koc University Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey. hyapici@ku.edu.tr.; Department of Psychiatry, Ankara Numune Training and Research Hospital, Ankara, Turkey.; Department of Psychiatry, Baskent University, School of Medicine, Ankara, Turkey.; Department of Psychiatry, Koc University Hospital, Istanbul, Turkey.; Department of Psychiatry, Ankara Numune Training and Research Hospital, Ankara, Turkey.; Safranbolu State Hospital, Kastamonu, Turkey.; Department of Psychiatry, Gazi University, Faculty of Medicine, Ankara, Turkey.
BT - Substance abuse treatment, prevention, and policy
C5 - Measures; Opioids & Substance Use
CP - 1
CY - England
DO - 10.1186/s13011-018-0166-1
IS - 1
JF - Substance abuse treatment, prevention, and policy
M1 - Journal Article
N2 - BACKGROUND: Cognitions associated with craving and substance use are important contributors for the psychological theories of Substance use disorders (SUD), as they may affect the course and treatment. In this study, we aimed to validate Turkish version of two major scales 'Beliefs About Substance Use'(BSU) and 'Craving Beliefs Questionnaire'(CBQ) in patients with heroin use disorder and define the interaction of these beliefs with patient profile, depression and anxiety symptoms, with an aim to use these thoughts as targets for treatment. METHODS: One hundred seventy-six inpatients diagnosed with heroin use disorder and 120 participants in the healthy comparison group were evaluated with CBQ, BSU, Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI) and sociodemographic data questionnaire. Patient group was also evaluated with Addiction Profile Index. Reliability and validity analysis for scales were conducted. Linear regression analysis was conducted to evaluate the determinants of BSU and CBQ scores. RESULTS: Cronbach alpha level was 0.93 for BSU and 0.94 for CBQ. Patient group showed significantly higher CBQ, BSU, BAI and BDI scores (p < 0.001). BSU score significantly correlated with API-substance use profile score, API-diagnosis, BAI, BDI and CBQ (p < 0.005), whereas CBQ scores significantly correlated with API-diagnosis, API-impact on life, API-craving, API-total score, BSU, BAI, BDI and amount of cigarette smoking (p < 0.002). Number of previous treatments and age of onset for substance use were not correlated with either BSU or CBQ. BAI and BDI scores significantly predicted BSU score, however only BDI score predicted CBQ score (p < 0.003). CONCLUSIONS: Craving beliefs were highly correlated with addiction profile. Anxiety and depression are significant modulators for patients' beliefs about substance use and depression is a modulator for craving and maladaptive beliefs, validating emotion-cognition interplay in addiction.
PP - England
PY - 2018
SN - 1747-597X; 1747-597X
SP - 29
T1 - Assessing the validity and reliability of the Turkish versions of craving beliefs and beliefs about substance use questionnaire in patients with heroin use disorder: demonstrating valid tools to assess cognition-emotion interplay
T2 - Substance abuse treatment, prevention, and policy
TI - Assessing the validity and reliability of the Turkish versions of craving beliefs and beliefs about substance use questionnaire in patients with heroin use disorder: demonstrating valid tools to assess cognition-emotion interplay
U1 - Measures; Opioids & Substance Use
U2 - 30134921
U3 - 10.1186/s13011-018-0166-1
VL - 13
VO - 1747-597X; 1747-597X
Y1 - 2018
Y2 - Aug 22
ER -